Abstract
Both the basal TSH concentration and the TSH response to iv TRH administration are noted to be decreased at the peak of an acute critical illness. Moreover, an impaired release from hypothalamus has been documented in rats with uncontrolled diabetes, suggesting hypothalamic dysfunction in a non-thyroidal illness. However, the exact inference and mechanism of this impaired TSH secretary pattern is not well defined in humans during a non-thyroidal illness. Therefore, this study assessed hypothalamic pituitary thyroid axis by determination by T4, T3, and T3 resin uptake prior to and TSH concentrations, prior to, as well as following, iv TRH administration at an interval of 30 min up to 2 hours on three successive mornings during a severe, critical, fatal illness in five previously known euthyroid subjects. TSH response to iv TRH administration was expressed as a maximal absolute change (Δ TSH) and a cumulative response (CR TSH), calculated as the sum of changes from the basal level at each specific time period for up to 120 min. Serum T4, T3 and TSH concentrations on day 1 of the TRH administration were significantly lower than normal values as well as the values documented previously in the same individuals prior to hospitalization. T3 resin uptake was increased simultaneously. Moreover, serum T4, T3, and T3 resin uptake remained significantly unaltered on three successive days of iv TRH administration. However, basal serum TSH rose significantly with a parallel TSH response to iv TRH administration, as reflected by a progressive rise in Δ TSH as well as CR TSH over this three-day period, with normalization of the TSH responses by the third day. Therefore, impaired TSH secretary pattern and altered thyroid hormone concentrations noted in subjects with acute critical illness may be attributed to the presence of a transient hypothalamic hypothyroidism.
Similar content being viewed by others
References
Wartofsky L., Burman K.D. Alterations in thyroid function in patients with systemic illnesses, “the euthyroid sick syndrome” Endocr. Rev. 1982, 3: 164.
Docter R., Krenning E.P., de Jong M., Hennemann G. The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin. Endocrinol. (Oxf.) 1993, 39: 499.
Chopra I.J. Nonthyroidal illness syndrome of euthyroid sick syndrome? Endocr. Prac. 1996, 2: 45.
McIver B., Gorman C.A. Euthyroid sick syndrome: An overview. Thyroid 1997, 7: 125.
De Groot L. Dangerous dogmas in medicine: The nonthyroidal illness syndrome. J. Clin. Endocrinol. Metab. 1999, 84: 151.
Bacci V., Schussler G.C., Kaplan T.B. The relationship between serum triiodothyronine and thyrotropin during systemic illness. J. Clin. Endocrinol. Metab. 1982, 54: 1129.
Vierhapper H., Laggner A., Waldhaus W., Grubeck-Lobenstein B., Kleinberger G. Impaired secretion of TSH in critically ill patients with “low-T4 syndrome”. Acta Endocrinol. (Copenh.) 1982, 101: 542.
Faber J., Kirkegaard C., Rasmussen B., West H., Busch-Sorensen M., Jensen I.W. Pituitary-thyroid axis in critical illness. J. Clin. Endocrinol. Metab. 1987, 63: 315.
Arem R., Deppe S. Fatal nonthyroidal illness may impair nocturnal thyrotropin levels. Am. J. Med. 1990, 88: 158.
Franklyn J.A., Black E.G., Betteridge J., Sheppard M.C. Comparison of second and third generation methods for measurement of serum thyrotropin in patients with overt hyperthyroidism, patients receiving thyroxine therapy, and those with nonthyroidal illness. J. Clin. Endocrinol. Metab. 1994, 78: 1368.
Blake G.N., Eckland J.A., Foster O.J.F., Lightman S.L. Inhibition of hypothalamic thyrotropin-releasing hormone messenger ribonucleic acid during food deprivation. Endocrinology 1991, 192: 1714.
Fliers E., Guldenaar S.E.F., Wiersinga W.M., Swaab D.F. Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. J. Clin. Endocrinol. Metab. 1997, 82: 4032.
Van den Berghe G., DeZegher F., Baxter R.C., et al. Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. J. Clin. Endocrinol. Metab. 1998, 83: 309.
Kabadi U.M., Kabadi S.U. Cumulative response: A reliable and accurate measurement of an integrated response during a dynamic test. Diabetes Res. 1996, 31: 77.
Kabadi U.M. Normal thyrotropin response to iv thyrotropin releasing hormone administration: The best index of L-thyroxine therapy in primary hypothyroidism. Postgrad. Med. J. 1985, 6: 685.
Kabadi U.M., Rosman P.M. Lack of influence of aging on hypothalamic pituitary thyroid axis in normal subjects. J. Clin. Exp. Gerontology. 1987, 9: 189.
Kabadi U.M., Rosman P.M. Thyroid hormone indices in adult healthy subjects: No influence of aging. J. Am. Geriatr. Soc. 1988, 36: 312.
Leroith D., Shapiro M., Luboshitsky R., Spitz M. The hypothalamic-pituitary axis in diabetes mellitus. Horm. Metab. Res. 1980, 12: 608.
Kabadi U.M. Impaired pituitary thyrotroph function in uncontrolled Type II diabetes mellitus: normalization on recovery. J. Clin. Endocrinol. Metab. 1984, 59: 521.
Lim V.S., Fang V.S., Katz A.I., Refetoff S. Thyroid dysfunction in chronic renal failure: A study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine. J. Clin. Invest. 1977, 60: 522.
Green J.R.B., Snitcher E.J., Mowat N.A.G., Rees L.H., Ekins R.P., Dawson A.M. Anomalous TSH secretion in liver disease: further evidence of hypothalamic-pituitary dysfunction. Gut 1976, 17: 395.
Hasen J., Boczko M., Donovan R., Giannini M. Blunted TSH response to TRH in patients with central nervous system disease. Am. J. Med. Sci. 1981, 281: 130.
Wilber J.F., Banerji A., Prasad C., Mori M. Alterations in hypothalamic-pituitary-thyroid regulation produced by diabetes mellitus. Life Sci. 1981, 28: 1757.
Kubota K., Uchimura H., Mitsuhashi T., Chiu S.C., Kuzuya N., Nagataki S. Effects of intrathyroidal metabolism of thyroxine on thyroid hormone secretion: increased degradation of thyroxine in mouse thyroids stimulated chronically with thyrotropin. Acta Endocrinol. (Copenh.) 1984, 105: 57.
Ikeda T., Honda M., Murakami I., Kuno S., Mokuda O., Tokumori Y., Tomimaga M., Mashiba H. Effect of TSH on conversion of T4 to T3 in perfused rat kidney. Metabolism 1985, 34: 1057.
Ikeda T., Takeuchi T., Ito Y., Murakami I., Mokuda O., Tominga M., Mashiba H. Effect of thyrotropin on conversion of T4 to T3 in perfused rat liver. Life Sci. 1986, 38: 1801.
Khorle J. Thyrotropin (TSH) action on thyroid hormone diodination and secretion: one aspect of thyrotropin regulation of thyroid cell biology. Horm. Metab. Res. Suppl. 1990, 23: 18.
Kabadi M.U. Role of thyrotropin in triiodothyronine generation in hypothyroidism. Thyroidol. Clin. Exp. 1993, 5: 41.
Chopra I.J. Clinical review 86: euthyroid sick syndrome: Is it a misnomer? J. Clin. Endocrinol. Metab. 1997, 82: 329–334.
Dyke C. The use of thyroid hormone in cardiac surgery. Curr. Opin. Cardiol. 1996, 11: 603–609.
Gomberg-Maitland M., Frishman W.H. Thyroid hormone and cardiovascular disease. Am. Heart J. 1998, 135: 186–196.
Reinhardt W., Mann K. “Non-thyroid illness” or changed thyroid hormone parameter syndrome with non-thyroid illnesses. Med. Klin. 1998, 93: 662–668.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kabadi, U.M. Thyrotropin dysregulation during a non-thyroidal illness: Transient hypothalamic hypothyroidism?. J Endocrinol Invest 24, 178–182 (2001). https://doi.org/10.1007/BF03343839
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343839